Saquinavir in the management of HIV infection
Moyle, G.
British Journal of Hospital Medicine 57(11): 560-564
1997
ISSN/ISBN: 0007-1064 PMID: 9307673 Document Number: 476299
Renewed optimism for the treatment of HIV infection has arisen with the advent of potent antiretroviral cocktails which, for many patients, provide sustained control of viral replication, and enable at least partial immune regeneration and improved quality of life. Proteinase inhibitor drugs, such as saquinavir, represent the key agents for attaining the new therapy goals.
Document emailed within 1 workday
Related Documents
Johnson, M.; Peters, B. 2003: Saquinavir/low-dose ritonavir: its use in HIV infection Aids Reviews 5(1): 44-51Cameron, D.W.; Japour, A.J.; Xu, Y.; Hsu, A.; Mellors, J.; Farthing, C.; Cohen, C.; Poretz, D.; Markowitz, M.; Follansbee, S.; Angel, J.B.; McMahon, D.; Ho, D.; Devanarayan, V.; Rode, R.; Salgo, M.; Kempf, D.J.; Granneman, R.; Leonard, J.M.; Sun, E. 1999: Ritonavir and saquinavir combination therapy for the treatment of HIV infection Aids 13(2): 213-224
Wheat, L.J.; Farthing, C.; Cohen, C.; Pierone, G.; Lalezari, J.; Pilson, R.S.; Siemon-Hryczyk, P. 2002: Efficacy and safety of twice-daily versus three-times daily saquinavir soft gelatin capsules as part of triple combination therapy for HIV-1 infection Antiviral Therapy 7(3): 199-209
Soria, A.; Gianotti, N.; Cernuschi, M.; Lazzarin, A. 2004: Once-daily saquinavir and ritonavir in treatment-experienced HIV-1-infected individuals New Microbiologica 27(1): 11-15
Jordan, W.C. 1998: The effectiveness of combined saquinavir and ketoconazole treatment in reducing HIV viral load Journal of the National Medical Association 90(10): 622-624
Nagot, N.; Ouedraogo, A.; Ouangre, A.; Cartoux, M.; Defer, M-Christine.; Meda, N.; Van de Perre, P. 2005: Is sexually transmitted infection management among sex workers still able to mitigate the spread of HIV infection in West Africa? Journal of Acquired Immune Deficiency Syndromes 39(4): 454-458
Nkoghe, D.; Moutschen, M.; Demonty, J. 2000: Guidelines for the management of patients with HIV infection. I. Adolescents and adults. Liege Working Group on HIV Infection Revue Medicale de Liege 55(5): 417-423
Washington, C.B.; Wiltshire, H.R.; Man, M.; Moy, T.; Harris, S.R.; Worth, E.; Weigl, P.; Liang, Z.; Hall, D.; Marriott, L.; Blaschke, T.F. 2000: The disposition of saquinavir in normal and P-glycoprotein deficient mice, rats, and in cultured cells Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(9): 1058-1062
Schmitz, V.; Nkoghe, D.; Hoyoux, C.; Dresse, M.F. 2000: Guidelines for the management of patients with HIV infection. II. Pregnant women and children. Liege Working Group on HIV Infection Revue Medicale de Liege 55(5): 424-429
Brites; Alcântara; Mosqueira; Gimbo; Pedroso; Pedral-Sampaio 1999: Safety and Efficacy of Reduced Doses of Ritonavir (RTV) Plus Saquinavir (SQV) in the Treatment of AIDS Patients in Brazil Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 3(3): 91-96
Ananworanich, J.; Hirschel, B.; Sirivichayakul, S.; Ubolyam, S.; Jupimai, T.; Prasithsirikul, W.; Chetchotisakd, P.; Kiertiburanakul, S.; Munsakul, W.; Raksakulkarn, P.; Tansuphasawadikul, S.; Schutz, M.; Snowden, W.; Ruxrungtham, K. 2006: Absence of resistance mutations in antiretroviral-naive patients treated with ritonavir-boosted saquinavir Antiviral Therapy 11(5): 631-635
Marcelin, A.-G.; Flandre, P.; de Mendoza, C.; Roquebert, B.; Peytavin, G.; Valer, L.; Wirden, M.; Abbas, S.; Katlama, C.; Soriano, V.; Calvez, V. 2007: Clinical validation of saquinavir/ritonavir genotypic resistance score in protease-inhibitor-experienced patients Antiviral Therapy 12(2): 247-252
Lamotte, C.; Landman, R.; Peytavin, G.; Mentre, F.; Gerbe, J.; Brun-Vezinet, F.ço.; Boue, F.ço.; Spiridon, G.; Valantin, M.-A.; Michelet, C.; Farinotti, R.; Yeni, P. 2004: Once-daily dosing of saquinavir soft-gel capsules and ritonavir combination in HIV-1-infected patients (IMEA015 study) Antiviral Therapy 9(2): 247-256
Maffeo, A.; Bellomi, F.; Solimeo, I.; Bambacioni, F.; Scagnolari, C.; De Pisa, F.; Dupuis, M.L.; Cianfriglia, M.; Antonelli, G.; Turriziani, O. 2004: P-glycoprotein expression affects the intracellular concentration and antiviral activity of the protease inhibitor saquinavir in a T cell line New Microbiologica 27(2 Suppl 1: 119-126
Kuschak, D.; Mauss, S.; Schmutz, G.; Gantke, B. 2001: Simultaneous Determination of the New HIV Protease Inhibitor Lopinavir (ABT 378) and of Indinavir (1), Amprenavir, Saquinavir, Ritonavir (ABT 538) (2) and Nelfinavir (3) in Human Plasma by Gradient HPLC Clinical Laboratory 47(9-10): 471-477
Manosuthi, W.; Sungkanuparph, S.; Ruxrungtham, K.; Prasithsirikul, W.; Athichathanabadi, C.; Tantisiriwat, W.; Bowonwatanuwong, C.; Chumpathat, N.; Chaovavanich, A. 2008: Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir Journal of Acquired Immune Deficiency Syndromes 47(1): 127-129
Chetchotisakd, P.; Anunnatsiri, S.; Wankun, J.; Mootsikapun, P.; Boonyaprawit, P. 2002: A randomized, open-label, comparative trial of BID and TID dosing of saquinavir enhanced oral formulation as part of a triple therapy for advanced AIDS patients Journal of the Medical Association of Thailand 85(5): 590-596
Reiser, M.; Salzberger, B.; Stiepel, A.; Hoetelmans, R.; Diehl, V.; Fätkenheuer, G. 1999: Virological efficacy and plasma drug concentrations of nelfinavir plus saquinavir as salvage therapy in HIV-infected patients refractory to standard triple therapy European Journal of Medical Research 4(2): 54-58
Ross, C.B.; Irwin, C.L.; Mukherjee, K.; Schumacher, P.M.; Dattilo, J.B.; Ranval, T.J.; Guzman, R.J.; Naslund, T.C. 2009: Vacuum-pack temporary abdominal wound management with delayed-closure for the management of ruptured abdominal aortic aneurysm and other abdominal vascular catastrophes: absence of graft infection in long-term survivors American Surgeon 75(7): 565-570; Discussion: 570-571
O'Brien, D.P.; Ford, N.; Vitoria, M.; Christinet, V.; Comte, E.; Calmy, A.; Stienstra, Y.; Eholie, S.; Asiedu, K. 2014: Management of BU-HIV co-infection Tropical Medicine and International Health: Tm and Ih 19(9): 1040-1047